Skip to Content

Clinical Trials Search Results

Showing 1-4 of 4

Sorted By:

  • Alliance A011502

    A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer.

  • Alliance A211601

    Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502

  • Natalee TRIO 033

    A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer.

  • NRG BR003

    A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer.